According to Nova one advisor, the global Soft Tissue Allografts market size is expected to hit around USD 6.45 billion by 2030 from valued at USD 3.84 billion in 2021 and growing at a CAGR of 5.30% from 2022 to 2030.
Soft tissue allografts are used to replace deficient ligaments, torn menisci, spinal surgery, and osteochondral defects during knee surgery. Donor screening, laboratory testing, and tissue preparation are part of the three-stage safety screening process for sterile tissue allografts. Soft tissue allografts are made up of bone, tendons, cartilage, skin, heart valves, and veins; and are used in various surgeries. Soft tissue allograft has been considered a successful procedure for over 150 years, with around 1 million allografts transplanted in the U.S. each year.
Usage of soft tissue allografts has increased across the globe due to the rise in number of orthopedic surgeries and dental implants. Increase in geriatric population, rise in demand for new technological advancements for the production of new tissues by tissue banks, and surge in demand for sterile soft tissue allografts among patients are augmenting the global soft tissue allografts market. Risk of infection and immune response could lead to serious complications such as disruption of infected anastomotic rigid line with a rupture, bowel formation, and microbial infection. Furthermore, high cost of procedures with limited reimbursement is likely to restrain the global soft tissue allografts market.
Report Scope of the Soft Tissue Allografts Market
Clinical Use in Medical Procedures and Sports Injuries to Drive Global Market
Modern training regimens in athletics, field events, and various other contact sports, such as American football, require athletes to participate in intensive training sessions that are often more strenuous than the sport itself. High-intensity training regimens are directly related to improved athletic performance; however, excessive training causes muscle and bone fatigue and frequently leads to injury.
Sports injury can be caused by an accident, an impact, poor training habits, lack of conditioning, improper equipment, and insufficient warm-up and stretching. Youth injuries are increasing as a result of year-round participation in a single sport. According to the American Academy of Pediatrics, around 30 million children and teenagers participate in organized sports in the U.S. each year, resulting in more than 3.5 million injuries. Sports-related injuries account for one-third of all childhood injuries.
Rise in Orthopedic and Dentistry Cases Associated with Aging to Augment Global Market
Elderly people are more likely to sustain soft tissue injuries. As people get older, they naturally slow down, have less energy, and are less powerful. Hence, they are more vulnerable to injuries. Falls is the leading cause of death among people aged over 65. It is the most common reason for elderly people to visit the emergency room.
Tooth loss is common among the geriatric population and can be caused by disease or trauma. Usage of dental implants to provide support for the replacement of missing teeth has a long and complex history. Research in dental implant designs, materials, and techniques has increased in the past few years. It is expected to rise in the near future due to the growth in the dental implants market and increase in demand for cosmetic dentistry. This is projected to drive the soft tissue allografts market size in the near future.
Increase in Number of Musculoskeletal Reconstructive Procedures Propelling Collagen Allografts Segment
In terms of product type, the collagen allografts segment dominated the global soft tissue allografts market in 2021. The trend is anticipated to continue during the forecast period. Rise in number of musculoskeletal reconstructive procedures such as anterior cruciate ligament reconstruction is likely to increase the usage of collagen allografts. Furthermore, increase in usage of collagen allografts in maxillofacial surgery and wound care therapies is expected to drive the segment during the forecast period.
Regional Analysis of Global Soft Tissue Allografts Market
North America dominated the global soft tissue allografts market in 2021. The market in the region is anticipated to grow at the fastest CAGR from 2022 to 2030 due to the presence of key players and high rate of technology adoption. Furthermore, prevalence of diabetic foot ulcers, better diabetes healthcare awareness programs, and increase in number of surgical procedures are augmenting the soft tissue allografts market share of North America.
Development of distribution channels by key players and rise in demand for collagen allografts for the treatment of severe burn injuries and breast reconstruction surgery are the factors driving the soft tissue allografts market in Asia Pacific.
Key Developments in Global Soft Tissue Allografts Market
- In August 2022, Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, announced the release of CYGNUS Matrix Disks, the newest configuration of the CYGNUS family of amniotic tissue allografts. CYGNUS amniotic tissue allografts are used to cover wounds. They act as soft tissue barriers to help prevent mechanical damage. CYGNUS Matrix Disk is a flexible, multi-layer allograft that preserves the amnion layer, its intermediate/spongy layer, and the chorion layers of the amniotic sac. It also offers better handling and increased workability.
- In August 2021, AlloSource introduced AlloMend Ultra-Thick Acellular Dermal Matrix (ADM), the newest addition to the AlloMend product line. The company is the largest allograft provider in the U.S. that develops cutting-edge cellular and tissue products to aid surgeons in healing patients. The thickest dermal graft offered by the company is AlloMend Ultra-Thick ADM, which is available in multiple sizes and has a thickness range of 3.0 mm to 4.0 mm. It is made using cutting-edge processing methods to guarantee that each allograft's thickness is constant throughout the entire graft. The product was created to be used in the replacement or repair of worn-out or insufficient tissue needed for difficult procedures such as superior capsule reconstruction (SCR).
Some of the prominent players in the Soft Tissue Allografts Market include:
- Lattice Biologics Ltd.
- Zimmer Biomet
- AlonSource Group
- MiMedix Group
- AlloSource
- CONMED Corporation
- Organogenesis, Inc.
- RTI Surgical, Inc.
- Osiris Therapeutics
- Integra LifeSciences Corporation
- Globus Medical, Inc.
- Straumann Holding AG
- Xtant Medical
- Alliqua BioMedical, Inc.
- C. R. Bard, Inc. (Davol, Inc.)
- B. Braun Melsungen AG
- Arthrex
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Soft Tissue Allografts market
- Product Type
- Cartilage Allografts
- Hyaline Cartilage
- Elastic Cartilage
- Fibro Cartilage
- Tendon Allografts
- Achilles Tendon
- Tibialis
- Patellar Tendon
- Hamstring
- Meniscus Allografts
- Dental Allografts
- Free Gingival Graft
- Connective Tissue Graft
- Pedicle Graft
- Collagen Allografts
- Amniotic Allografts
- Application
- Orthopedic
- Sports Medicine
- Spine Surgeries
- General Orthopedic
- Reconstruction
- Dentistry
- Dental Sensitivity
- Aesthetics
- Wound Care
- Others
- End-user
- Hospitals
- Orthopedic Clinics
- Dental Clinics
- Ambulatory Surgical Centers
- Aesthetic Centers
By Geography
North America
Europe
- Germany
- France
- United Kingdom
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Soft Tissue Allografts industry analysis from 2022 to 2030 to identify the prevailing Soft Tissue Allografts industry opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the global Soft Tissue Allografts industry segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global Soft Tissue Allografts industry trends, key players, market segments, application areas, and market growth strategies.
Request Customization
Get a Sample
Get a Sample
Request Customization